NVST
Envista Holdings Corp
NYSE: NVST · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$25.90
-2.23% today
Updated 2026-04-29
Market cap
$4.22B
P/E ratio
92.50
P/S ratio
1.55x
EPS (TTM)
$0.28
Dividend yield
—
52W range
$16 – $30
Volume
2.4M
Envista Holdings Corp (NVST) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $417.00M | $359.10M | $400.10M | $397.50M | $283.90M | $361.60M | $182.70M | $275.70M | $336.50M | $275.70M |
| Capital expenditures | $49.10M | $48.90M | $72.20M | $77.80M | $47.70M | $54.70M | $75.70M | $58.20M | $33.80M | $45.30M |
| Depreciation | $127.20M | $121.40M | $130.00M | $168.10M | $163.10M | $151.90M | $162.10M | $162.60M | $154.50M | $116.00M |
| Stock-based comp | $10.50M | $12.30M | $13.30M | $18.40M | $22.60M | $28.20M | $30.50M | $30.70M | $35.30M | $37.60M |
| Free cash flow | $367.90M | $310.20M | $327.90M | $319.70M | $236.20M | $306.90M | $107.00M | $217.50M | $302.70M | $230.40M |
| Investing cash flow | $-59.40M | $-54.90M | $-75.50M | $-78.40M | $-69.10M | $262.70M | $-657.30M | $-62.40M | $-54.60M | $-51.10M |
| Financing cash flow | $-357.60M | $-304.20M | $-324.60M | $-107.70M | $492.50M | $-465.60M | $12.50M | $118.90M | $-103.70M | $-170.90M |
| Dividends paid | $0.00 | $0.00 | $0.00 | — | $8.80M | $12.30M | $12.70M | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | $0.00 | $0.00 | $0.00 | — | $707.30M | $158.70M | $-462.10M | — | — | — |